The Open Parasitology Journal
2010, 4 : 111-115Published online 2010 December 10. DOI: 10.2174/1874421401004010111
Publisher ID: TOPARAJ-4-111
RESEARCH ARTICLE
The trans-Sialidase from a Putative Target for Trypanocidal Agents
* Address correspondence to this author at the Instituto de Biofísica Carlos Chagas Filho, Centro de Ciências da Saúde – Bloco G, Universidade Federal do Rio de Janeiro – 21 944 970, Cidade Universitária, Ilha do Fundão, Rio de Janeiro-RJ, Brasil; Tel: +552125626646; Fax: +552122808193; E-mail: luciamp@biof.ufrj.br
ABSTRACT
Trypanosomatid protozoa are parasites of considerable medical and economical importance because they are the causative agents of chronic human and livestock diseases endemic in developing countries. Trypanosoma cruzi is the causative agent of Chagas´ disease, present in most of Latin America. The biology of this parasite presents some unusual features, one of which is the mechanism employed for the addition of sialic acid units to its own glycoproteins, the mucinlike molecules, or to exogenous glycoconjugates. This is mediated by a transglycosylase for sialic acid known as transsialidase and located on the external surface of the parasite, rather than by an intracellular CMP-sialic acid-dependent sialyltransferase. The Trypanosoma cruzi trans-sialidase is thought to play an important role in the pathogenesis of Chagas’ disease, and it represents a potential therapeutic target.